Published On: October 12, 201610MD receives funding from Swelife
10MD has received funding from the Swedish Innovation Programme for Life Science, SWElife. The funding will primarily be used to support 10MD market access activities.
Published On: September 26, 201610MD project member of Production 2030
10MD was chosen as one of the first SME companies in Sweden to be part of Production 2030 - a strategic initiative for sustainable production.
Published On: August 1, 201610MD attracts private equity
Ten Medical Design AB (10MD) has raised 1M SEK in a funding round to a few selected private investors and Almi Företagspartner AB, owned by the Swedish government. The funding will primarily be used to finalize the development of TeXray.
Published On: May 10, 2016Ergonomic assessment of a unique 10MD product
The Centre for Health Technology has performed an ergonomic assessment of a prototype based on the unique TeXray technology platform.
Published On: March 1, 2016Collaboration with Swerea IVF – Technology and Growth
Swerea IVF develops and implements new technologies and new working methods within a range of sectors focusing on product, process and production development.
Published On: December 9, 201510MD receives funding from Vinnova
Ten Medical Design (10MD) receives additional funding from Vinnova, the Swedish governmental agency for innovation systems.
Published On: October 7, 2015Grant of patent application
The Swedish Patent- and Registration Office (PRV) has decided to grant Ten Medical Design AB (10MD) patent application SE537818 for TeXray (NAFT) radiation protective textile material.
Published On: February 20, 2015TeXray further tested for its efficacy and safety
Ten Medical Design AB (10MD) has performed further laboratory tests of TeXray, the newly developed material for radiation protection.
Published On: November 1, 201410MD receives additional funding
Ten Medical Design (10MD) receives funding from Swerea IVF.
Published On: October 1, 201410MD strengthens team
Ten Medical Design (10MD) strengthens the team to prepare the company to move from a late development stage to a commercialization phase.
